S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 2, 2022
November 1, 2022
1d41223b-0838-4b9d-ad50-e8e6371d700e
Related Documents
E8(R1) General Considerations for Clinical Studies
Guidance DocumentApril 8, 2022Center for Drug Evaluation and Research
M10 Bioanalytical Method Validation and Study Sample Analysis
Guidance DocumentNovember 4, 2022Center for Drug Evaluation and Research
Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff
Guidance DocumentNovember 24, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox